Skip to content

Effect of Peony-Glycyrrhiza Decoction to Amisulpride-induced Hyperprolactinemia in Women with Schizophrenia

Effect of Peony-Glycyrrhiza Decoction to Antipsychotic drugs-induced Hyperprolactinemia in Schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012930
Enrollment
Unknown
Registered
2017-10-10
Start date
2014-01-01
Completion date
Unknown
Last updated
2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Peony-Glycyrrhiza Decoction (PGD):Peony-Glycyrrhiza Decoction

Sponsors

Brains Hospital of Hunan Province
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. taking Amisulpride monotherapy for at least 3 months; 2. stable mental state, stable treatment for at least 3 months, and PANSS scores was less than 60; 3. level of serum PRL was greater than 24 ng/mL; 4. at least one overt hyperprolactinemia-related symptom, including amenorrhea, abnormal menstruation, galactorrhea, reduced libido or sexless; 5. screening negative for pregnancy in women and agreed to use effective contraception methods during the study. The protocol of this study was approved by the medical ethical committee of Brains Hospital of Hunan Province. All participants and their guardians were given the voluntary, written, and informed consent before entering the trial.

Exclusion criteria

Exclusion criteria: 1. PRL pituitary adenoma, polycystic ovary syndrome and other serious somatic diseases; 2. a history of neuroleptic malignant syndrome or tardive dyskinesia; 3. suicide ideas or attempts, or aggressive behavior; 4. a history of alcoholism and drug abuse in the past 1 year; 5. currently treated with other endocrine drugs, Chinese medicine and other natural products; 6. a history of allergy to herbal medicine; 7. lactating.

Design outcomes

Primary

MeasureTime frame
Prolactin;Progesterone;Estradiol;FSH;LH;PASNN;

Secondary

MeasureTime frame
Hepatorenal function;glucose, serum lipids;thyroid function;

Countries

China

Contacts

Public ContactYang Ping

Brains Hospital of Hu'nan Province

cuteping12384@126.com+86 15111069360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026